Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
Weibo Le(Nanjing General Hospital of Nanjing Military Command), Qing Yang(Guangzhou University of Chinese Medicine), Caihong Zeng(Nanjing University), Yihui Zhai(Wenzhou Medical University), Feng Xu(Zhejiang Chinese Medical University), Zhangsuo Liu(First Affiliated Hospital of Henan University of Traditional Chinese Medicine), Ying Wu(Hainan University), Qian Huang(Southwest University), Xiaoqing Yang(Rutgers, The State University of New Jersey), Zhongmin Fan(Shanghai Jiao Tong University), Hao Chen(China Institute of Atomic Energy), Zhihong Liu(Chinese Academy of Sciences), Dong Liu(Army Medical University), Jianming Wang(China-Japan Friendship Hospital), Ying Ding(First Affiliated Hospital of Henan University of Traditional Chinese Medicine), Rui-Xia Lin(Wenzhou Medical University), Hongbing Shen(Jiangsu Cancer Hospital), Guanghua Zhu(Shanghai Jiao Tong University)
Cited by 86
Related Papers
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
|Journal of Clinical Oncology|2011|1.3k
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
|Kidney International|2017|1.2k
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
|Nature Genetics|2017|804
Genomic instability in laminopathy-based premature aging
|Nature Medicine|2005|641